Skip to main content

    Main navigation

    • Investors
    • About
    • News
    • Contact us
    • Egoo.health
    • en
    • sv
Home

Main navigation

  • Investors
  • About
  • News
  • Contact us
  • Egoo.health
  • en
  • sv
2019-10-14 10:51

Qlife participates at Intrum Stockholm Open on 18 October 2019!

Six interesting companies in total will present their businesses.

Watch the video of the presentation

2025-12-12 08:30
Egoo Health powers AI-driven personalized diabetes management in China
2025-12-05 11:13
Qlife’s Birmingham PKU clinical trial published with strong results – key milestone toward CE-mark submission and market launch
2025-11-14 17:37
Update on the reverse takeover process – “Red Chip” structure will not be approved by Nasdaq – other structures are pursued
2025-11-12 08:30
QLIFE HOLDING AB, Interim Report Q3, July - September 2025
2025-10-05 17:00
The Letter of Intent with Hipro Biotechnology Co., Ltd. regarding reverse takeover has been extended
2025-09-22 18:00
Qlife Holding AB announces the outcome of the exercise of warrants series TO 6
2025-09-15 08:30
Qlife announces additional product line and progresses two new tests into clinical trials
2025-08-27 08:30
QLIFE HOLDING AB, Interim Report Q2, April to June 2025
2025-08-27 08:00
Progress update on the reverse takeover process between Qlife and Hipro

Qlife

Qlife Holding AB
Nellickevägen 22
SE-412 63 Göteborg
info@egoo.health
Last published: 2025-02-10

Links

  • About
  • Investors
  • Egoo.health

Qlife is born to challenge the status quo in healthcare. We work to shift the perspective and turn today's view on health-care into tomorrow's focus on health-empowerment. We are on a quest to empower people with more accessible ways to understand their health - so that they can move beyond reactive care towards proactive wellbeing. it's how we contribute to improving quality of life for every individual and for the greater society.